KennethShindlerMDPhD
Ophthalmology • Philadelphia, PANeuro-Ophthalmology
Associate Professor of Ophthalmology and Neurology
Dr. Shindler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
51 N 39th St
Philadelphia, PA 19104Phone+1 215-662-8042- Is this information wrong?
Education & Training
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2000 - 2003
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1999 - 2000
Washington University in St. Louis School of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2000 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Comparison of Brn3a and RBPMS Labeling to Assess Retinal Ganglion Cell Loss During Aging and in a Model of Optic Neuropathy.Miranda Meng, Brahim Chaqour, Nuala O'Neill, Kimberly Dine, Neha Sarabu, Gui-Shuang Ying, Kenneth S Shindler, Ahmara G Ross> ;Investigative Ophthalmology & Visual Science. 2024 Apr 1
- AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes.Brahim Chaqour, Thu T Duong, Jipeng Yue, Tehui Liu, David Camacho, Kimberly E Dine, Julian Esteve-Rudd, Scott Ellis, Jean Bennett, Kenneth S Shindler, Ahmara G Ross> ;Gene Therapy. 2024 Mar 1
- 2 citationsNanoparticles Enhance Solubility and Neuroprotective Effects of Resveratrol in Demyelinating Disease.Ehtesham Shamsher, Reas S Khan, Benjamin M Davis, Kimberly Dine, Vy Luong, Satyanarayana Somavarapu, M Francesca Cordeiro, Kenneth S Shindler> ;Neurotherapeutics. 2023 Jul 1
- Join now to see all
Other
- RGC Neuroprotection Following Optic Nerve Trauma Mediated by Intranasal Delivery of Amnion Cell SecretomeKenneth Shindler, MD, Investigative Ophthalmology and Visual Science
https://www.doximity.com/articles/b2c40819-4f30-4b0b-b39e-11541972f692
UpToDate, Wolters Kluwer Health - 2012-10-12
Press Mentions
Noveome Biotherapeutics, Inc. Announces Preliminary Results of Its Phase 1 Open Label Clinical Trial Evaluating Intranasal Delivery of Lead Candidate ST266 in Glaucoma Suspect PatientsJune 7th, 2021- Neuroprotection Mediated by ST266 Requires Full Complement of Proteins Secreted by Amnion-Derived Multipotent Progenitor CellsJanuary 6th, 2021
Noveome Biotherapeutics, Inc. Announces Publication of Further Preclinical Results Supporting the Neuroprotective Properties of ST266 in Retinal Ganglion CellsMay 9th, 2019- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
